Skip to content
A

Amena Khatun Manica

Publications (2)

From Pharmacophore to Free Energy: A Multi Scale Approach to DJ 1 (PARK7) Inhibitor Identification

Amena Khatun Manica, Ejoke Akatugba, Kesiena Loveth Eguono, Fisayo Wasilat Adeyemo, Precious-Esther Ogechi Efuneshi, Pruthvirajsinh Rajendrasinh Solanki, Dhruvilkumar Narendrakumar Patel, Bernard Opeyemi Adedeji, Abraham Olayeri, Adeyemi Ogunbowale, Joshua Temitope Adekeye & Idris Oladimeji Junaid · International Journal of Biochemistry Research & Review · 2025

DJ-1 (PARK7), a multifunctional protein implicated in both neurodegeneration and oncogenesis, remains an underexploited therapeutic target due to limitations in the structural and dynamic interrogation of its ligand-binding landscape. In this study, we employed an integrated comp...

Open access Research Article 10.9734/ijbcrr/2025/v34i61079

Unveiling Novel KRAS G12V Inhibitors: A Comprehensive Study Using Computer-aided Drug Design Approach

Amena Khatun Manica, Benedicta Quainoo, Jonathan Cudjoe, Aminat Motunrayo Adekunle, Cyril Agadagba, Temilade Rukayat Adeniran, Oluwatosin Oluwafunmilola Oluwafemi, Ayomide Daniel Oluwafemi, Abasiodiong Ekanem, Hikmat Opeyemi Sulaiman, Farimah Mohammadi, Emmanuel Parkay Oladokun, Mariam Omowunmi Oguntunji & Roheemah Olamide Oni · International Journal of Biochemistry Research & Review · 2025

The KRAS G12V mutation is a formidable oncogenic driver implicated in the pathogenesis of several aggressive cancers, including pancreatic ductal adenocarcinoma, non-small cell lung cancer, and colorectal cancer. Overcoming the historical challenges associated with targeting KRAS...

Open access Research Article 10.9734/ijbcrr/2025/v34i2978